Dr. Simpson is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1653 W Congress Pkwy
# 1591
Chicago, IL 60612Phone+1 312-942-8114Fax+1 312-942-8975
Summary
- Dr. Mindy Simpson is a pediatric hematologist/oncologist in Chicago, IL and is affiliated with multiple hospitals in the area, including Rush University Medical Center and Rush-Copley Medical Center. She received her medical degree from Lewis Katz School of Medicine at Temple University and has been in practice 14 years. She specializes in pediatric coagulation disorder hematology and pediatric platelet disorder hematology and is experienced in platelet disorders, hemophilia a, hemophilia, pediatric coagulation disorders, and pediatric hematology and oncology. She has more than 20 publications and over 500 citings.
Education & Training
- University of ColoradoFellowship, Pediatric Hematology/Oncology, 2007 - 2010
- McGaw Medical Center of Northwestern UniversityResidency, Pediatrics, 2003 - 2006
- Lewis Katz School of Medicine at Temple UniversityClass of 2003
Certifications & Licensure
- IL State Medical License 2005 - 2026
- CO State Medical License 2007 - 2011
- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Hematology-Oncology
Clinical Trials
- Evaluation of the Duration of Therapy for Thrombosis in Children Start of enrollment: 2008 Mar 01
Publications & Presentations
PubMed
- 1 citationsDamoctocog Alfa Pegol, a PEGylated B-domain Deleted Recombinant Extended Half-life Factor VIII for the Treatment of Hemophilia A: A Product Review.Mark T Reding, Shadan Lalezari, Gili Kenet, Giovanni Di Minno, Jonathan Ducore
Drugs in R&D. 2024-09-01 - Long-Term Efficacy and Safety of Damoctocog Alfa Pegol Prophylaxis in Patients with Haemophilia A Aged 12-<18 Years at Enrolment into PROTECT VIII.Mark T Reding, Mindy Simpson, Jonathan Ducore, Pål Andrè Holme, Monika Maas Enriquez
Acta Haematologica. 2024-04-23 - 4 citationsAnalysis of pooled real-world data from Germany, Italy, and the United States of rVIII-SingleChain compared with standard- and long-acting FVIII products for prophylax...Martin Olivieri, Mindy Simpson, Songkai Yan, Johanna Fedorovsky, Xiang Zhang
Current Medical Research and Opinion. 2022-07-01
Press Mentions
- Study Suggests Another Look at Common Treatments for HemophiliaJune 13th, 2016
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: